Literature DB >> 7783697

Enteric and mild hyperoxaluria.

R A Sutton1, V R Walker.   

Abstract

Enteric hyperoxaluria complicates extensive disease or resection of the small intestine in the presence of an intact colon, and is associated with calcium oxalate nephrolithiasis. In addition to hyperoxaluria these patients have a low urine volume, low urinary ionic strength and hypocitraturia. Many forms of treatment have been recommended, but none has been subjected to a prospective clinical trial. Mild idiopathic hyperoxaluria is reported in 8-50% of idiopathic calcium oxalate stoneformers. Several pathophysiological mechanisms have been proposed, including low dietary calcium and possible oxalate transport defects in the gut and/or the kidney. Mild hyperoxaluria, or a high oxalate:calcium ratio in the urine, may be particularly important risk factors for calcium oxalate stone formation; an approach to the correction of these abnormalities is proposed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7783697

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  9 in total

1.  Problems in the investigation of urine from patients suffering from primary hyperoxaluria type 1.

Authors:  N Laube; B Hoppe; A Hesse
Journal:  Urol Res       Date:  2005-09-08

Review 2.  Oxalate transport and calcium oxalate renal stone disease.

Authors:  C F Verkoelen; J C Romijn
Journal:  Urol Res       Date:  1996

3.  Urinary oxalate excretion in urolithiasis and nephrocalcinosis.

Authors:  T J Neuhaus; T Belzer; N Blau; B Hoppe; H Sidhu; E Leumann
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

4.  Risk factors associated to kidney stones in primary hyperparathyroidism.

Authors:  S Corbetta; A Baccarelli; A Aroldi; L Vicentini; G B Fogazzi; C Eller-Vainicher; C Ponticelli; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

Review 5.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 6.  Cell cultures and nephrolithiasis.

Authors:  C F Verkoelen; B G van der Boom; F H Schröder; J C Romijn
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

7.  Net intestinal transport of oxalate reflects passive absorption and SLC26A6-mediated secretion.

Authors:  Felix Knauf; Narae Ko; Zhirong Jiang; William G Robertson; Christina M Van Itallie; James M Anderson; Peter S Aronson
Journal:  J Am Soc Nephrol       Date:  2011-10-21       Impact factor: 10.121

8.  Epidemiological profile, mineral metabolic pattern and crystallographic analysis of urolithiasis in Kuwait.

Authors:  K el-Reshaid; H Mughal; M Kapoor
Journal:  Eur J Epidemiol       Date:  1997-02       Impact factor: 8.082

Review 9.  Animal models of naturally occurring stone disease.

Authors:  Ashley Alford; Eva Furrow; Michael Borofsky; Jody Lulich
Journal:  Nat Rev Urol       Date:  2020-11-06       Impact factor: 16.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.